Expertise in
9
conditions

Mark S. Spence

Belfast, NIR, GB 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
9
conditions
Belfast, NIR, GB 

Overview

Mark Spence practices practicing medicine in Belfast, United Kingdom.

Mr. Spence is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Aortic Valve Stenosis, Aortic Regurgitation, Patent Foramen Ovale, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.

He is actively involved in clinical research, co-authoring 112 peer reviewed articles and participating in 6 clinical trials.

Gender

Male

Locations

Belfast, NIR, United Kingdom
Other Locations
Antrim, NIR, United Kingdom
Whitworth Street, Manchester, ENG M16LT, United Kingdom
Cambridge, ENG, United Kingdom
London, ENG SW36NP, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Expanded Study of the HighLife 28mm Trans-septal Trans-catheter Mitral Valve in Patients With Moderate-severe or Severe Mitral Regurgitation and at High Surgical Risk
Expanded Study of the HighLife 28mm Trans-septal Trans-catheter Mitral Valve in Patients With Moderate-severe or Severe Mitral Regurgitation and at High Surgical Risk
Enrollment Status: Recruiting
Publish Date: September 15, 2025
Intervention Type: Device
Study Phase: Not Applicable
Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation (ASAP-TOO)
Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation (ASAP-TOO)
Enrollment Status: Terminated
Publish Date: August 25, 2026
Intervention Type: Device, Drug
Study Phase: Not Applicable
Transcatheter Repair of Mitral Regurgitation With Edwards PASCAL Transcatheter Valve Repair System: A European Prospective, Multicenter Post Market Clinical Follow-Up (PMCF)
Transcatheter Repair of Mitral Regurgitation With Edwards PASCAL Transcatheter Valve Repair System: A European Prospective, Multicenter Post Market Clinical Follow-Up (PMCF)
Enrollment Status: Active_not_recruiting
Publish Date: August 19, 2026
Intervention Type: Device
Safety and Performance Evaluation of the AccuCinch® Ventricular Restoration System for the Treatment of Heart Failure With or Without Functional Mitral Regurgitation Due to Dilated Ischemic or Non-Ischemic Cardiomyopathy - The CorCinch-EU Study
Safety and Performance Evaluation of the AccuCinch® Ventricular Restoration System for the Treatment of Heart Failure With or Without Functional Mitral Regurgitation Due to Dilated Ischemic or Non-Ischemic Cardiomyopathy - The CorCinch-EU Study
Enrollment Status: Active_not_recruiting
Publish Date: January 29, 2025
Intervention Type: Device
Study Phase: Not Applicable
Repositionable Lotus Edge™ Valve System - Post Market Evaluation of Real World Clinical Outcomes
Repositionable Lotus Edge™ Valve System - Post Market Evaluation of Real World Clinical Outcomes
Enrollment Status: Terminated
Publish Date: July 15, 2021
Intervention Type: Device
Feasibility And Safety of Early Discharge After Transfemoral Transcatheter Aortic Valve Implantation The FAST-TAVI Study
Feasibility And Safety of Early Discharge After Transfemoral Transcatheter Aortic Valve Implantation The FAST-TAVI Study
Enrollment Status: Completed
Publish Date: October 23, 2020
Intervention Type: Device
View 5 Less Clinical Trials

112 Total Publications

Association of the T-786C polymorphism of the nitric oxide synthase 3 gene with acute coronary syndrome or premature coronary artery disease: A systematic review and meta-analysis.
Association of the T-786C polymorphism of the nitric oxide synthase 3 gene with acute coronary syndrome or premature coronary artery disease: A systematic review and meta-analysis.
Journal: Cytokine
Published: June 17, 2026

Frequently Asked Questions about Mark S. Spence

Is Mark S. Spence a top-rated expert for Aortic Valve Stenosis?

MediFind is an objective health platform that identifies experts based on real-world data. Mark S. Spence is classified as an Distinguished expert for Aortic Valve Stenosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Mark S. Spence participate in research or clinical trials?

Yes. Mark S. Spence has published 112 articles and abstracts on conditions like Aortic Valve Stenosis. You can view a list of Mark S. Spence's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Spence's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 22 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile